Stocks

The table gives an overview of all stocks, alphabetically sorted.
 C Security CSEC Mar 4, 2021 0.30 -10.48   
 C-RAD B CRADB Mar 4, 2021 58.90 -1.01   
 Cadeler AS CADLRO Mar 4, 2021 24.70 0.00   
 CAG Group CAG Mar 4, 2021 70.80 +0.85   
 Calliditas Therapeutics CALTX Mar 4, 2021 120.80 -2.58   
 Calmark B CALMAB Mar 4, 2021 8.50 +0.59   
 Camurus CAMX Mar 4, 2021 221.50 -2.64   
 Cantargia CANTA Mar 4, 2021 49.85 -0.70   
 Capacent Holding CAPAC Mar 4, 2021 47.30 +1.07   
 Carasent CARAO Mar 4, 2021 34.40 0.00   
 Carbiotix CRBX Mar 4, 2021 17.50 -3.85   
 Castellum CAST Mar 4, 2021 204.10 +0.34   
 Catella A CATA Mar 4, 2021 30.40 0.00   
 Catella B CATB Mar 4, 2021 29.80 -0.33   
 Catena CATE Mar 4, 2021 391.50 +0.90   
 Catena Media CTM Mar 4, 2021 43.18 +0.05   
 Cavotec SA CCC Mar 4, 2021 21.10 -0.47   
 CDON CDON Mar 4, 2021 721.00 -2.57   
 Cell Impact B CIB Mar 4, 2021 40.80 -6.64   
 CellaVision CEVI Mar 4, 2021 293.60 -0.81   
 CELLINK B CLNKB Mar 4, 2021 380.50 -2.44   
 Cereno Scientific B CRNOB Mar 4, 2021 1.87 0.00   
 Cessatech CESSA Mar 4, 2021 18.32 0.00   
 CGit B CGITB Mar 4, 2021 41.80 +3.47   
 Chordate Medical Holding CMH Mar 4, 2021 0.52 -6.31   
 Christian Berner Tech Trade B CBTTB Mar 4, 2021 31.70 0.00   
 ChromoGenics CHRO Mar 4, 2021 10.36 -4.07   
 Cibus Nordic Real Estate CIBUS Mar 4, 2021 161.40 -0.49   
 Cint Group AB CINT Mar 4, 2021 84.00 0.00   
 CirChem CIRCHE Mar 4, 2021 18.35 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK